Zobrazeno 1 - 10
of 89
pro vyhledávání: '"H. Zschiedrich"'
Autor:
A, Overlack, M, Adamczak, W, Bachmann, G, Bönner, R G, Bretzel, R, Derichs, W, Krone, R M, Lederle, H J, Reimann, H, Zschiedrich
Publikováno v:
The American journal of medicine. 97(2)
Many hypertensive patients have other, usually long-term diseases. Antihypertensive therapy may interfere with these diseases and their therapies. In the present study, the possible interactions of the ACE-inhibitor perindopril with several of the mo
Autor:
H, Zschiedrich
Publikováno v:
Arzneimittel-Forschung. 43(2A)
Angiotensin converting enzyme (ACE) inhibitors have been accepted as drugs of first choice in the treatment of hypertension beside beta-blockers, diuretics and calcium antagonists. ACE inhibitors are effective, well tolerated and produce a small rate
Kniha
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 3:73-93
1. Isolated rat kidneys were perfused at a constant pressure of 90 mmHg in a single-pass system with either a cell-free medium or a suspension of washed bovine red blood cells, free of the components of the renin-angiotensin system. In red blood cell
Publikováno v:
Klinische Wochenschrift. 61:661-667
In 14 patients with essential hypertension, the influence of the alpha- and beta-adrenoceptor blocking drug labetalol on blood pressure, heart rate, plasma renin, plasma noradrenaline and pressor effect of exogenous noradrenaline was investigated dur
Publikováno v:
Klinische Wochenschrift. 60:293-301
After withdrawal of 400 ml whole blood and subsequent infusion of 500 ml of a colloidal plasma substituent, the intravascular and renal colloid elimination was investigated in 40 test subjects. The individual colloidal solutions could no longer be de
Publikováno v:
Experimental Biology and Medicine. 142:796-799
Publikováno v:
Klinische Wochenschrift. 55:917-919
Bei 7 Patienten mit Hypertonie bei einseitiger Nierenarterienstenose sowie einem Patienten mit Hypertonie bei einseitiger pyelonephritischer Schrumpfniere wurde der Einflus des Angiotensin II-Antagonisten Saralasin auf die Hamodynamik untersucht. Die